ClearBridge LLC (Maryland)’s Novo Nordisk NVO Stock Holding History

ClearBridge LLC (Maryland)’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-246,994	Closed	-$5.7M	–	140
2018 Q2	$5.7M	Buy	246,994 +80,800	+49%	+$1.92M	0.1%	133
2018 Q1	$4.09M	Sell	166,194 -23,206	-12%	-$609K	0.09%	140
2017 Q4	$5.08M	Buy	189,400 +92,000	+94%	+$2.34M	0.11%	135
2017 Q3	$2.35M	Hold	97,400	–	–	0.05%	138
2017 Q2	$2.09M	Hold	97,400	–	–	0.04%	135
2017 Q1	$1.67M	Sell	97,400 -36,940	-27%	-$643K	0.04%	140
2016 Q4	$2.41M	Hold	134,340	–	–	0.05%	132
2016 Q3	$2.79M	Hold	134,340	–	–	0.05%	131
2016 Q2	$3.61M	Hold	134,340	–	–	0.07%	125
2016 Q1	$3.64M	Sell	134,340 -400	-0.3%	-$10.7K	0.07%	125
2015 Q4	$3.91M	Buy	+134,740	New	+$3.73M	0.07%	123

Other funds holding NVO

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

ClearBridge LLC (Maryland)'s NVO Position: Q3 2018 in Review

ClearBridge LLC (Maryland) sold out of Novo Nordisk (NVO) in Q3 2018, closing a stake of 246,994 shares — an estimated $5.7M sold.

ClearBridge LLC (Maryland) first reported a position in NVO in Q4 2015 and held it in 11 quarters. The position peaked at $5.7M in Q2 2018. 557 funds tracked by Wall St. Rank hold NVO as of Q3 2018.

ClearBridge LLC (Maryland) reported no remaining Novo Nordisk position as of Q3 2018 after selling out during the quarter.
ClearBridge LLC (Maryland) sold 246,994 Novo Nordisk shares in Q3 2018, an estimated $5.7M.
ClearBridge LLC (Maryland) first reported a position in Novo Nordisk in Q4 2015 and held it in 11 quarters.
ClearBridge LLC (Maryland)'s Novo Nordisk position peaked at $5.7M in Q2 2018.
557 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2018.

Based on ClearBridge LLC (Maryland)'s 13F filing for Q3 2018, filed 14 Nov 2018.